Berberine prevents the apoptosis of mouse podocytes induced by TRAF5 overexpression by suppressing NF-κB activation

  • Authors:
    • Feng Wu
    • Dong-Sheng Yao
    • Tian-Ying Lan
    • Chen Wang
    • Jian-Dong Gao
    • Li-Qun He
    • Di Huang
  • View Affiliations

  • Published online on: November 7, 2017     https://doi.org/10.3892/ijmm.2017.3236
  • Pages: 555-563
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Berberine (BBR) has previously been found to exert beneficial effects on renal injury in experimental rats. However, the mechanisms underlying these effects are not yet fully understood. Tumor necrosis factor (TNF) receptor-associated factor 5 (TRAF5) has been demonstrated to mediate the activation of nuclear factor-κB (NF-κB), which has been implicated in the pathogenesis of chronic kidney disease (CKD). The aim of this study was to investigate the effects of BBR on kidney injury and the activation of the NF-κB signaling pathway in mouse podocytes. TRAF5 was found to be overexpressed in patients with CKD and chronic renal failure (CRF) (data obtained from the dataset GSE48944, as well as from patients at Shuguang Hospital). TRAF5 overexpression significantly inhibited cell viability and induced the apoptosis of mouse podocytes. However, BBR prevented the decrease in cell viability and the apoptosis induced by TRAF5 overexpression. The NF-κB inhibitor, caffeic acid phenethyl ester (CAPE), mimicked the protective effects of BBR, as evidenced by the increased expression of nephrin and podocin, and the decreased the expression of caspase-3 and the ratio of Bax/Bcl-2. Moreover, BBR prevented the decrease in cell viability decrease and the apoptosis induced by TNF-α, interleukin (IL)-6 and lipopolysaccharide (LPS). Taken together, our data indicate that BBR exerts protective effects against CRF partly through the TRAF5-mediated activation of the NF-κB signaling pathway in mouse podocytes.

References

1 

Ortiz A, Covic A, Fliser D, Fouque D, Goldsmith D, Kanbay M, Mallamaci F, Massy ZA, Rossignol P, Vanholder R, et al Board of the EURECA-m Working Group of ERA-EDTA: Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet. 383:1831–1843. 2014. View Article : Google Scholar : PubMed/NCBI

2 

Stengel B: Chronic kidney disease and cancer: A troubling connection. J Nephrol. 23:253–262. 2010.PubMed/NCBI

3 

Hsu CY, Ordoñez JD, Chertow GM, Fan D, McCulloch CE and Go AS: The risk of acute renal failure in patients with chronic kidney disease. Kidney Int. 74:101–107. 2008. View Article : Google Scholar : PubMed/NCBI

4 

Kalantar-Zadeh K, Block G, Humphreys MH and Kopple JD: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 63:793–808. 2003. View Article : Google Scholar : PubMed/NCBI

5 

Ortiz A, Massy ZA, Fliser D, Lindholm B, Wiecek A, Martínez-Castelao A, Covic A, Goldsmith D, Süleymanlar G, London GM, et al: Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis. Nat Rev Nephrol. 8:141–150. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Shidfar F, Ebrahimi SS, Hosseini S, Heydari I, Shidfar S and Hajhassani G: The effects of Berberis vulgaris fruit extract on serum lipoproteins, apoB, apoA-I, homocysteine, glycemic control and total antioxidant capacity in type 2 diabetic patients. Iran J Pharm Res. 11:643–652. 2012.PubMed/NCBI

7 

Wang Y, Campbell T, Perry B, Beaurepaire C and Qin L: Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats. Metabolism. 60:298–305. 2011. View Article : Google Scholar

8 

Zha W, Liang G, Xiao J, Studer EJ, Hylemon PB, Pandak WM Jr, Wang G, Li X and Zhou H: Berberine inhibits HIV protease inhibitor-induced inflammatory response by modulating ER stress signaling pathways in murine macrophages. PLoS One. 5:e90692010. View Article : Google Scholar : PubMed/NCBI

9 

Katiyar SK, Meeran SM, Katiyar N and Akhtar S: p53 cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Mol Carcinog. 48:24–37. 2009. View Article : Google Scholar

10 

Jiang Q, Liu P, Wu X, Liu W, Shen X, Lan T, Xu S, Peng J, Xie X and Huang H: Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: Involvement of NF-κB signaling pathway. Mol Cell Endocrinol. 331:34–40. 2011. View Article : Google Scholar

11 

Ichikawa H, Takada Y, Murakami A and Aggarwal BB: Identification of a novel blocker of IκBα kinase that enhances cellular apoptosis and inhibits cellular invasion through suppression of NF-κB-regulated gene products. J Immunol. 174:7383–7392. 2005. View Article : Google Scholar : PubMed/NCBI

12 

Jackson-Bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG, Chaturvedi MM and Aggarwal BB: Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene. 26:1385–1397. 2007. View Article : Google Scholar

13 

Korchnak AC, Zhan Y, Aguilar MT and Chadee DN: Cytokine-induced activation of mixed lineage kinase 3 requires TRAF2 and TRAF6. Cell Signal. 21:1620–1625. 2009. View Article : Google Scholar : PubMed/NCBI

14 

Khan KA, Abbas W, Varin A, Kumar A, Di Martino V, Dichamp I and Herbein G: HIV-1 Nef interacts with HCV Core, recruits TRAF2, TRAF5 and TRAF6, and stimulates HIV-1 replication in macrophages. J Innate Immun. 5:639–656. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Tada K, Okazaki T, Sakon S, Kobarai T, Kurosawa K, Yamaoka S, Hashimoto H, Mak TW, Yagita H, Okumura K, et al: Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-κB activation and protection from cell death. J Biol Chem. 276:36530–36534. 2001. View Article : Google Scholar : PubMed/NCBI

16 

Tao T, Cheng C, Ji Y, Xu G, Zhang J, Zhang L and Shen A: Numbl inhibits glioma cell migration and invasion by suppressing TRAF5-mediated NF-κB activation. Mol Biol Cell. 23:2635–2644. 2012. View Article : Google Scholar : PubMed/NCBI

17 

Ko YA, Mohtat D, Suzuki M, Park AS, Izquierdo MC, Han SY, Kang HM, Si H, Hostetter T, Pullman JM, et al: Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development. Genome Biol. 14:R1082013. View Article : Google Scholar : PubMed/NCBI

18 

Wang LN, Wang Y, Lu Y, Yin ZF, Zhang YH, Aslanidi GV, Srivastava A, Ling CQ and Ling C: Pristimerin enhances recombinant adeno-associated virus vector-mediated transgene expression in human cell lines in vitro and murine hepatocytes in vivo. J Integr Med. 12:20–34. 2014. View Article : Google Scholar : PubMed/NCBI

19 

Saha SK, Roy S and Khuda-Bukhsh AR: Ultra-highly diluted plant extracts of Hydrastis canadensis and Marsdenia condurango induce epigenetic modifications and alter gene expression profiles in HeLa cells in vitro. J Integr Med. 13:400–411. 2015. View Article : Google Scholar : PubMed/NCBI

20 

Wu D, Wen W, Qi CL, Zhao RX, Lü JH, Zhong CY and Chen YY: Ameliorative effect of berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocin. Phytomedicine. 19:712–718. 2012. View Article : Google Scholar : PubMed/NCBI

21 

Shen J, Qiao YQ, Ran ZH and Wang TR: upregulation and pre-activation of TRAF3 and TRAF5 in inflammatory bowel disease. Int J Med Sci. 10:156–163. 2013. View Article : Google Scholar :

22 

Ruiz-Ballesteros E, Mollejo M, Rodriguez A, Camacho FI, Algara P, Martinez N, Pollán M, Sanchez-Aguilera A, Menarguez J, Campo E, et al: Splenic marginal zone lymphoma: Proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. Blood. 106:1831–1838. 2005. View Article : Google Scholar : PubMed/NCBI

23 

Horie R and Watanabe T, Ito K, Morisita Y, Watanabe M, Ishida T, Higashihara M, Kadin M and Watanabe T: Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells. Am J Pathol. 160:1647–1654. 2002. View Article : Google Scholar : PubMed/NCBI

24 

Missiou A, Rudolf P, Stachon P, Wolf D, Varo N, Aichele P, Colberg C, Hoppe N, Ernst S, Münkel C, et al: TRAF5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formation. Circ Res. 107:757–766. 2010. View Article : Google Scholar : PubMed/NCBI

25 

Su VY-F and Yang K-Y: Mesenchymal stem cell-conditioned medium induces neutrophils apoptosis via inhibition of NF-κB pathway and increases endogenous pulmonary stem cells in endotoxin-induced acute lung injury. Eur Respir J. 46(Suppl 59): OA35202015.

26 

Arora R, Yates C, Gary BD, McClellan S, Tan M, Xi Y, Reed E, Piazza GA, Owen LB and Dean-Colomb W: Panepoxydone targets NF-κB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer. PLoS One. 9:e983702014. View Article : Google Scholar

27 

Chen F, Wang M, O'Connor JP, He M, Tripathi T and Harrison LE: Phosphorylation of PPARgamma via active ERK1/2 leads to its physical association with p65 and inhibition of NF-kappabeta. J Cell Biochem. 90:732–744. 2003. View Article : Google Scholar : PubMed/NCBI

28 

Eschwege P1, Paradis V, Conti M, Loric S, Dumas F, Berteau P, Ahmed M, Droupy S, Charpentier B, Legrand A, et al: Bcl-2 and Bax expression on rat ischemic kidney. Transplant Proc. 30:2861–2862. 1998. View Article : Google Scholar : PubMed/NCBI

29 

Saikumar P, Dong Z, Patel Y, Hall K, Hopfer U, Weinberg JM and Venkatachalam MA: Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene. 17:3401–3415. 1998. View Article : Google Scholar

30 

Chien CT, Chang TC, Tsai CY, Shyue SK and Lai MK: Adenovirus-mediated bcl-2 gene transfer inhibits renal ischemia/reperfusion induced tubular oxidative stress and apoptosis. Am J Transplant. 5:1194–1203. 2005. View Article : Google Scholar : PubMed/NCBI

31 

Ikezumi Y, Suzuki T, Karasawa T, Kawachi H, Nikolic-Paterson DJ and Uchiyama M: Activated macrophages downregulate podocyte nephrin and podocin expression via stress-activated protein kinases. Biochem Biophys Res Commun. 376:706–711. 2008. View Article : Google Scholar : PubMed/NCBI

32 

Perysinaki GS, Moysiadis DK, Bertsias G, Giannopoulou I, Kyriacou K, Nakopoulou L, Boumpas DT and Daphnis E: Podocyte main slit diaphragm proteins, nephrin and podocin, are affected at early stages of lupus nephritis and correlate with disease histology. Lupus. 20:781–791. 2011. View Article : Google Scholar : PubMed/NCBI

33 

Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, Ye JM, Lee CH, Oh WK, Kim CT, et al: Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 55:2256–2264. 2006. View Article : Google Scholar : PubMed/NCBI

34 

Derosa G, Maffioli P and Cicero AF: Berberine on metabolic and cardiovascular risk factors: An analysis from preclinical evidences to clinical trials. Expert Opin Biol Ther. 12:1113–1124. 2012. View Article : Google Scholar : PubMed/NCBI

35 

Lan T, Shen X, Liu P, Liu W, Xu S, Xie X, Jiang Q, Li W and Huang H: Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK-S1P signaling pathway. Arch Biochem Biophys. 502:112–120. 2010. View Article : Google Scholar : PubMed/NCBI

36 

Chen L, Guo W, Zhang S, Lu W, Liao S and Li Y: Berberine prevents high glucose-induced cell viability inhibition and apoptosis in podocytes. Int J Clin Exp Med. 9:5942–5950. 2016.

37 

Wan X, Chen X, Liu L, Zhao Y, Huang WJ, Zhang Q, Miao GG, Chen W, Xie HG and Cao CC: Berberine ameliorates chronic kidney injury caused by atherosclerotic renovascular disease through the suppression of NFκB signaling pathway in rats. PLoS One. 8:e597942013. View Article : Google Scholar

Related Articles

Journal Cover

January 2018
Volume 41 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wu, F., Yao, D., Lan, T., Wang, C., Gao, J., He, L., & Huang, D. (2018). Berberine prevents the apoptosis of mouse podocytes induced by TRAF5 overexpression by suppressing NF-κB activation. International Journal of Molecular Medicine, 41, 555-563. https://doi.org/10.3892/ijmm.2017.3236
MLA
Wu, F., Yao, D., Lan, T., Wang, C., Gao, J., He, L., Huang, D."Berberine prevents the apoptosis of mouse podocytes induced by TRAF5 overexpression by suppressing NF-κB activation". International Journal of Molecular Medicine 41.1 (2018): 555-563.
Chicago
Wu, F., Yao, D., Lan, T., Wang, C., Gao, J., He, L., Huang, D."Berberine prevents the apoptosis of mouse podocytes induced by TRAF5 overexpression by suppressing NF-κB activation". International Journal of Molecular Medicine 41, no. 1 (2018): 555-563. https://doi.org/10.3892/ijmm.2017.3236